ANI Pharmaceuticals
ANIP
$65.36
Share price
0.63%
Change (1 day)
73.28%
Change (1 year)
Categories
ANI Pharmaceuticals (ANIP) - Net assets
Net assets on the balance sheet as of December 2023 : $0.45 B
According to ANI Pharmaceuticals's latest financial reports the company has $0.45 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
ANI Pharmaceuticals - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.45 B | 35.17% |
| 2022-12-31 | $0.33 B | -5.63% |
| 2021-12-31 | $0.35 B | 83.31% |
| 2020-12-31 | $0.19 B | -8.03% |
| 2019-12-31 | $0.21 B | 7.87% |
| 2018-12-31 | $0.19 B | 12.88% |
| 2017-12-31 | $0.17 B | 3.01% |
| 2016-12-31 | $0.16 B | 5.98% |
| 2015-12-31 | $0.16 B | 14.52% |
| 2014-12-31 | $0.13 B | 241.26% |
| 2013-12-31 | $40.96 M | 45.38% |
| 2012-12-31 | $28.17 M | -25.49% |
| 2011-12-31 | $37.81 M | 97.5% |
| 2010-12-31 | $19.14 M | 20.95% |
| 2009-12-31 | $15.83 M | 14.49% |
| 2008-12-31 | $13.82 M | -53.49% |
| 2007-12-31 | $29.72 M | 64.49% |
| 2006-12-31 | $18.07 M | 165.02% |
| 2005-12-31 | $6.81 M | -57.17% |
| 2004-12-31 | $15.92 M | 83.33% |
| 2003-12-31 | $8.68 M | 87.83% |
| 2002-12-31 | $4.62 M | 14.12% |
| 2001-12-31 | $4.05 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $39.75 B | 8,587.96% | 🇨🇭 Switzerland |
 Pfizer PFE | $89.28 B | 19,412.28% | 🇺🇸 USA |
 Cardinal Health CAH | -$3.45 B | -853.28% | 🇺🇸 USA |
 Jazz Pharmaceuticals JAZZ | $3.73 B | 716.65% | 🇮🇪 Ireland |
 Evoke Pharma
EVOK | -$2.58 M | -100.56% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $0.42 B | -6.21% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $8.12 B | 1,675.79% | 🇮🇱 Israel |
 Royalty Pharma RPRX | $10.08 B | 2,103.74% | 🇬🇧 UK |
 Lannett Company LCI | -$0.42 B | -190.09% | 🇺🇸 USA |